Skip to main content
Premium Trial:

Request an Annual Quote

Microbix Taps Thomas Scientific as US Distribution Partner for Dx Quality Assessment Products

NEW YORK — Microbix Biosystems said on Wednesday that it has signed a US distribution deal for its quality assessment products with Thomas Scientific.

Under the terms of the deal, Swedesboro, New Jersey-based Thomas Scientific will provide customer service, sales and marketing, distribution, and related logistical support for Microbix's quality assessment products, or QAPs.

Additional terms were not disclosed.

Mississauga, Ontario-based Microbix offers more than 70 quality assessment products to support the accuracy of infectious disease diagnostic tests, including ones for molecular assays that detect SARS-CoV-2 variants of concern.

Thomas Scientific is Microbix's second US distribution partner. In early 2020, Microbix inked a similar deal with Alpha-Tec Systems.

"We're aiming for the US market to achieve 10 [times] the QAPs revenue we do in Canada, and now with [Thomas Scientific's] 175 active sales professionals generating leads and five molecular specialists helping close them, our targets should be achieved," Phil Casselli, senior VP of sales and business development at Microbix, said in a statement.

Last month, Microbix signed on SDT Molecular to distribute its products in Hong Kong, Indonesia, Malaysia, and Singapore.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.